GATA-3 Suppression by DNAzyme Modulates Interleukin-10 and Liver Injury Markers in db/db Mice
Layla Al-Mansoori, Asma A. Elashi, Laila Hedaya, Maha Alser, Shamma Almuraikhy, Najeha Anwardeen, Hend Al-Jaber, Suhad Hussain, Hamda A. Al-Naemi, Vijay Govindharajan, Rafif Mahmood Al-Saady, Mohammed Imad Malki, Khaled Naja, Mohamed A. Elrayess · 2025
Read GATA-3 Suppression by DNAzyme Modulates Interleukin-10 and Liver Injury Markers in db/db Mice by Layla Al-Mansoori, Asma A. Elashi, Laila Hedaya, Maha Alser, Shamma Almuraikhy, Najeha Anwardeen, Hend Al-Jaber, Suhad Hussain, Hamda A. Al-Naemi, Vijay Govindharajan, Rafif Mahmood Al-Saady, Mohammed Imad Malki, Khaled Naja, Mohamed A. Elrayess (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12784981.txt.
Description
Al-Mansoori and thirteen co-authors published a 2025 mouse study of suppressing GATA-3, a gene switch tied to fat growth and inflammation, as a possible lever against obesity-linked disease. Obese diabetic mice received injections of a DNA-cutting molecule aimed at GATA-3, at low or high dose, twice weekly for two weeks. A standard diabetes drug served as positive control, and vehicle injections as negative control.
Suppression did not shift fat distribution or organ weights clearly. The low dose briefly sped weight gain and raised an anti-inflammatory signal, interleukin-10, in liver and blood. The high dose markedly reduced a form of liver cell injury called ballooning. The authors say the results hint at anti-inflammatory and liver-protective effects worth pursuing. They call for longer studies before any therapeutic claims.
Catalog record
| CREATOR | Layla Al-Mansoori, Asma A. Elashi, Laila Hedaya, Maha Alser, Shamma Almuraikhy, Najeha Anwardeen, Hend Al-Jaber, Suhad Hussain, Hamda A. Al-Naemi, Vijay Govindharajan, Rafif Mahmood Al-Saady, Mohammed Imad Malki, Khaled Naja, Mohamed A. Elrayess |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 33 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |